PPA
CADX

Parametric Portfolio Associates’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Parametric Portfolio Associates’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-14,643
Closed -$133K – 3907
2013
Q4 		$133K Buy
14,643
+666
+5% +$4.81K ﹤0.01% 3698
2013
Q3 		$88K Sell
13,977
-4,868
-26% -$30.9K ﹤0.01% 3731
2013
Q2 		$129K Buy
+18,845
New +$131K ﹤0.01% 3563

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Parametric Portfolio Associates's CADX Position: Q1 2014 in Review

Parametric Portfolio Associates sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 14,643 shares — an estimated $133K sold.

Parametric Portfolio Associates first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $133K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Parametric Portfolio Associates reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Parametric Portfolio Associates sold 14,643 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $133K.
  • Parametric Portfolio Associates first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
  • Parametric Portfolio Associates's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $133K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Parametric Portfolio Associates's 13F filing for Q1 2014, filed 13 May 2014.